Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 518037Generated: October 31, 2026

Cyclopropylboronic acid → 8-Benzyl-3-cyclopropyl-6,7,8,9-tetrahydropyrazino[2,3-f][1,4]oxazepine

https://huagongshe.com/reaction/518037

Reaction equation

Participants

RoleNameHCIDCharge
ReactantCyclopropylboronic acidHCID 2760897—
ReactantTricyclopropylphosphaneHCID 12716772—
ReactantPotassium tert-butoxideHCID 23665647—
Reactant8-Benzyl-3-chloro-6,7,8,9-tetrahydropyrazino[2,3-f][1,4]oxazepineHCID 86648981—
Catalystpalladium(II) acetateHCID 167845—
SolventWaterHCID 962—
SolventTolueneHCID 1140—
Product8-Benzyl-3-cyclopropyl-6,7,8,9-tetrahydropyrazino[2,3-f][1,4]oxazepineHCID 6699331516%

Reaction Conditions

Temperature100 °C

Reaction Steps

A suspension of 8-benzyl-3-chloro-6,7,8,9-tetrahydropyrazino[2,3-f][1,4]oxazepine (493 mg), cyclopropylboronic acid (280 mg), palladium acetate (20 mg), tricyclopropylphosphine (51 mg) and potassium tert-butoxide (663 mg) in toluene (8 mL) was stirred under an argon atmosphere with heating at 100° C. for 2 hr. Water was added to the reaction mixture, the aqueous layer was extracted with ethyl acetate, and the organic layer was washed with saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (solvent gradient: 5→25% ethyl acetate/hexane) to give the title compound (79.9 mg, 16%) as a colorless oil.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09115139B2
Source datasetuspto-grants-2015_08
ORD IDord-c533418b47af4ab6856aa35ae89dd03a
Source noteuspto-grants-2015_08